Clinical Trials Directory

Trials / Suspended

SuspendedNCT04810624

Relapse Prevention and Changing Habits in Anorexia Nervosa

Optimizing Relapse Prevention and Changing Habits in Anorexia Nervosa

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.

Detailed description

While many approaches to reducing relapse after hospital care have been tried, there is little information about which treatment elements confer benefit. This trial, Relapse Prevention and Changing Habits (REACH+), targets the habitual control of maladaptive behavior to support patients with AN in the 6 months after acute treatment, a time of high vulnerability to relapse. Each component of REACH+ addresses a question that is critical to answer in order to identify and optimize a relapse prevention treatment package that balances efficacy and burden. We will test the acceptability and feasibility of 5 components that together target habits: 1) Behavioral, 2) Cognitive, 3)Motivation, 4) Food Monitoring, and 5) Skill Consolidation. In the Preparation Phase, 10 participants were enrolled, and accessibility and feasibility of the treatment package was examined. The current Optimization Phase includes a finalized treatment manual (including an online platform) and will test each component's contribution to weight maintenance after acute treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRelapse Prevention and Changing Habits (REACH+)Psychotherapy

Timeline

Start date
2021-06-21
Primary completion
2027-06-30
Completion
2027-06-30
First posted
2021-03-23
Last updated
2026-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04810624. Inclusion in this directory is not an endorsement.